The tyrosine phosphatase Shp-2 interacts with the dopamine D1 receptor and triggers D1-mediated Erk signaling in striatal neurons

Journal of Neurochemistry

Volumn 117, Issue 2, 2011, Pages 253-263

  Fiorentini, Chiara ^a   Mattanza, Cinzia ^a   Collo, Ginetta ^a   Savoia, Paola ^a   Spano, PierFranco ^a   Missale, Cristina ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cyclic AMP; Dopamine receptors; Protein kinase A; RNA silencing; Striatal cultures

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE SHP 2; SMALL INTERFERING RNA;

ARTICLE; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; BENZAZEPINES; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOPRECIPITATION; NEURONS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RATS; RECEPTORS, DOPAMINE D1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TYROSINE;

RATTUS;

EID: 79953698416     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07196.x     Document Type: Article

References (37)

1. Agazie Y. M. and Hayman M. J. (2003) Molecular mechanism for a role of Shp-2 in epidermal growth factor receptor signalling. Mol. Cell. Biol. 23, 7875-7886.
2. Araki T., Yamada M., Ohnishi H., Sano S., Uetsuki T. and Hatanaka H. (2000) Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons. J. Neurochem. 74, 659-668. (Pubitemid 30053738)
3. Bibb J. A., Snyder G. L., Nishi A. et al. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669-671. (Pubitemid 129516337)
4. Chan G., Kalaitzidis D. and Neel B. G. (2008) The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev. 27, 179-192.
5. Chen J., Rusnak M., Lombroso P. J. and Sidhu A. (2009) Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. Eur. J. Neurosci. 29, 287-306.
6. Duchene J., Schanstra J. P., Pecher C., Pizard A., Susini C., Esteve J. P., Bascands J. L. and Girolami J. P. (2002) A novel protein - protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J. Biol. Chem. 277, 40375-40383.
7. Fiorentini C., Busi C., Gorruso E., Gotti C., Spano P. F. and Missale C. (2008) Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol. Pharmacol. 74, 59-69.
8. Florio T. (2008) Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases. Mol. Cell. Endocrinol. 286, 40-48.
9. Gerfen C. R., Miyachi S., Paletzki R. and Brown P. (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054. (Pubitemid 37465618)
10. Gerfen C. R., Paletzki R. and Worley P. (2008) Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J. Neurosci. 28, 7113-7120.
11. Guillemot L., Levy A., Zhao Z. J., Bereziat G. and Rothhut B. (2000) The protein - tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHOAT1A cells. J. Biol. Chem. 275, 26349-26358.
12. Hanafusa H., Torli S., Yasunaga T., Matsumoto K. and Nishida E. (2004) Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signalling by dephosphorylating and inactivating the inhibitor Sprouty. J. Biol. Chem. 279, 22992-22995.
13. Liu L., Yen J. H. and Ganea D. (2007) A novel VIP signalling pathway in T cells: cAMP-protein tyrosine phosphatase (SHP-2?)-JAK2/STAT4-Th1 differentiation. Peptides 28, 1814-1824. (Pubitemid 47361412)
14. Luttrell L. M., Daaka Y. and Lefkowitz R. J. (1999) Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11, 177-183.
15. MacDonald J. A. and Storey K. B. (2007) The effect of hibernation on protein phosphatases from ground squirrel organs. Arch. Biochem. Biophys. 468, 234-243.
16. Missale C., Nash S. R., Robinson S. W., Jaber M. and Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
17. Montagner A., Yart A., Dance M., Perret B., Salles J. P. and Raynal P. (2005) A novel role for Gab1 and Shp2 in epidermal growth factor-induced Ras activation. J. Biol. Chem. 280, 5350-5360.
18. Neel B. G., Gu H. and Pao L. (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signalling. Trends Biochem. Sci. 28, 284-293.
19. Nishi A., Bibb J. A., Snyder G. L., Higashi H., Nairn A. C. and Greengard P. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl Acad. Sci. USA 97, 12840-12845.
20. Obara Y., Labudda K., Dillon T. J. and Stork P. J. (2004) PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J. Cell Sci. 117, 6085-6094. (Pubitemid 40123973)
21. Poole A. W. and Jones M. L. (2005) A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell. Signal. 17, 1323-1332.
22. Ravetch J. V. and Lanier L. L. (2000) Immune inhibitory receptors. Science 290, 84-89.
23. Ren Y., Meng S., Mei L., Zhao Z. J., Jove R. and Wu J. (2004) Roles of Gab1 and Shp2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J. Biol. Chem. 279, 8497-8505.
24. Rocchi S., Gaillard I., van Obberghen E., Chambaz E. M. and Vilgrain I. (2000) Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase. Biochem. J. 352, 483-490. (Pubitemid 32011442)
25. Samayawardhena L. A., Hu J., Stein P. L. and Craig A. W. (2006) Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Cell. Signal. 18, 1447-1454.
26. Santini E., Valjent E., Usiello A., Carta M., Borgkvist A., Girault J. A., Hervé D., Greengard P. and Fisone G. (2007) Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J. Neurosci. 27, 6995-7005. (Pubitemid 47015907)
27. Svenningsson P., Nishi A., Fisone G., Girault J. A., Nairn A. C. and Greengard P. (2004) DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44, 269-296.
28. Tang H., Zhao Z. J., Huang X. Y., Landon E. J. and Inagami T. (1999) Fyn kinase-directed activation of SH2 domain-containing proteintyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells. J. Biol. Chem. 274, 12401-12407.
29. Thomas G. M. and Huganir R. L. (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183.
30. Tsui F. W., Martin A., Wang J. and Tsui H. W. (2006) Investigations into the regulation and function of the SH2 domain-containing proteintyrosine phosphatase SHP-1. Immunol. Res. 35, 127-136.
31. Valjent E., Pascoli V., Svenningsson P. et al. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 102, 91-496.
32. Vatinel S., Ferrand A., Lopez F., Kowalski-Chauvel A., Estive J. P., Fourmy D., Dufresne M. and Seva C. (2006) An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway. Biochem. Biophys. Acta 1763, 1098-1107.
33. Voulalas P. J., Holtzclaw L., Wolstenholme J., Russell J. T. and Hyman S. E. (2005) Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons. J. Neurosci. 25, 3763-3773. (Pubitemid 40570409)
34. Westin J. E., Vercammen L., Strome E. M., Konradi C. and Cenci M. A. (2007) Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol. Psychiatry 62, 800-810. (Pubitemid 47374647)
35. Yang W., Klaman L. D., Chen B., Araki T., Harada H., Thomas S. M., George E. L. and Neel B. G. (2006) An Shp2/SFK/Ras/Erk signalling pathway controls trophoblast stem cell survival. Cell 10, 317-327.
36. Zhang H., Conrad D. M., Butler J. J., Zhao C., Blay J. and Hoskin D. W. (2004) Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3′,5′-monophosphate and phosphatases. J. Immunol. 173, 932-944. (Pubitemid 38924266)
37. Zhuang X., Belluscio L. and Hen R. (2000) G(olf)alpha mediates dopamine D1 receptor signaling. J. Neurosci. 20, RC91.